James C King

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants
    James C King
    Department of Pediatrics, School of Medicine, University of Maryland, Baltimore, USA
    J Pediatr Gastroenterol Nutr 44:245-51. 2007
  2. ncbi request reprint Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children
    J C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Pediatr Infect Dis J 20:1124-31. 2001
  3. doi request reprint Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Vaccine 27:6589-94. 2009
  4. ncbi request reprint A pilot study of the effectiveness of a school-based influenza vaccination program
    James C King
    Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Pediatrics 116:e868-73. 2005
  5. ncbi request reprint Effectiveness of school-based influenza vaccination
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
    N Engl J Med 355:2523-32. 2006
  6. doi request reprint Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland
    James C King
    University of Maryland School of Medicine, Department of Pediatrics, USA
    Vaccine 28:7737-42. 2010
  7. doi request reprint Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Vaccine 31:839-44. 2013
  8. doi request reprint Direct and indirect impact of influenza vaccination of young children on school absenteeism
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Vaccine 30:289-93. 2012
  9. doi request reprint Successful use of volunteers to conduct school-located mass influenza vaccination clinics
    Ginny E Cummings
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Pediatrics 129:S88-95. 2012
  10. doi request reprint Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial
    Jordana Schmier
    MedImmune Inc in Gaithersburg, Maryland, USA
    Health Aff (Millwood) 27:w96-104. 2008

Detail Information

Publications17

  1. ncbi request reprint A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants
    James C King
    Department of Pediatrics, School of Medicine, University of Maryland, Baltimore, USA
    J Pediatr Gastroenterol Nutr 44:245-51. 2007
    ..The aim of this randomized, placebo-controlled, double-blind study was to examine the impact of bovine lactoferrin supplementation in infants...
  2. ncbi request reprint Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children
    J C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Pediatr Infect Dis J 20:1124-31. 2001
    ..To assess the safety of live, attenuated influenza vaccine (LAIV) administered to relatively asymptomatic or mildly symptomatic HIV-infected children and non-HIV-infected children...
  3. doi request reprint Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Vaccine 27:6589-94. 2009
    ..Recombinant baculovirus-expressed hemagglutinin (rHA [FluBlok]) influenza vaccine is unique in avoiding production in eggs and its rapid production capability...
  4. ncbi request reprint A pilot study of the effectiveness of a school-based influenza vaccination program
    James C King
    Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Pediatrics 116:e868-73. 2005
    ..The objective of this study was to evaluate the feasibility of a school-based influenza immunization program...
  5. ncbi request reprint Effectiveness of school-based influenza vaccination
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
    N Engl J Med 355:2523-32. 2006
    ..Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities...
  6. doi request reprint Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland
    James C King
    University of Maryland School of Medicine, Department of Pediatrics, USA
    Vaccine 28:7737-42. 2010
    ..I., 3-9%) in adults aged >50 years for every 20% increase in vaccination rates (p<0.023) for which we have no plausible biologic explanation. No significant changes in deaths were noted...
  7. doi request reprint Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Vaccine 31:839-44. 2013
    ..A/H3N2 viruses were clearly associated with more frequent MAARI-related ED visits and hospitalizations than A/H1N1 and B viruses...
  8. doi request reprint Direct and indirect impact of influenza vaccination of young children on school absenteeism
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Vaccine 30:289-93. 2012
    ..05). These results suggest both direct and indirect benefits of influenza vaccination of young children...
  9. doi request reprint Successful use of volunteers to conduct school-located mass influenza vaccination clinics
    Ginny E Cummings
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Pediatrics 129:S88-95. 2012
    ..To determine the feasibility of using volunteers to assist in school-located mass vaccination clinics for influenza...
  10. doi request reprint Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial
    Jordana Schmier
    MedImmune Inc in Gaithersburg, Maryland, USA
    Health Aff (Millwood) 27:w96-104. 2008
    ..The results show that immunization reduces disease among children and adults and is cost-saving to society. An epidemiologically based influenza immunization policy might be an important supplement to the existing risk-based policy...
  11. doi request reprint Countywide school-based influenza immunization: direct and indirect impact on student absenteeism
    Mollie M Davis
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland 21205, USA
    Pediatrics 122:e260-5. 2008
    ..We examined the impact of this community-based intervention on countywide student absenteeism during the subsequent influenza outbreak...
  12. ncbi request reprint Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults
    James D Campbell
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    J Infect Dis 186:1848-51. 2002
    ....
  13. ncbi request reprint Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults
    J C King
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Infect Dis 181:725-8. 2000
    ..The data suggest that inadvertent vaccination with LAIV in relatively asymptomatic HIV-infected adults would not be associated with frequent significant adverse events...
  14. ncbi request reprint Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus
    J C King
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Infect Dis 181:1817-21. 2000
    ..Heterologous, noninfecting group seroresponses were detected frequently (72%) in the paired serum samples from these 4 homologous group seroresponders...
  15. doi request reprint Pediatrician attitudes concerning school-located vaccination clinics for seasonal influenza
    Virginia A Keane
    University of Maryland Department of Pediatrics, 737 W Lombard Street, Baltimore, MD 21201, USA
    Pediatrics 129:S96-S100. 2012
    ..We determined the degree to which pediatricians support routine annual influenza vaccination outside the medical home, especially in school-located mass influenza vaccination clinics...
  16. ncbi request reprint Administration of palivizumab: a medical provider's perspective
    Elizabeth A Helm
    Department of Pediatrics, Division of General Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland 21201 1512, USA
    Clin Pediatr (Phila) 42:821-6. 2003
  17. ncbi request reprint The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans
    Peter F Wright
    Division of Pediatric Infectious Disease, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    J Infect Dis 193:573-81. 2006
    ..In the present study, the NS2 gene, whose encoded protein antagonizes the host's interferon- alpha / beta response, was deleted from RSV vaccine candidates by use of reverse genetics...